Promoting eSource Data Capture

The U.S. Food and Drug Administration (FDA) reiterates that it “clearly promotes” capturing source data electronically – and is a […]

Infographic: eSource vs. EDC

See how eSource streamlines data capture, providing validated data for remote review in minutes — as opposed to weeks with […]

Site Experience

Intuitive eSource for Optimal Site Efficiency

An effective eSource solution must be intuitive enough to effectively make clinical research easier. From the beginning, Clinical Ink’s SureSource® platform was designed for optimal site efficiency. Developed and tested with actual site users, SureSource is the only eSource solution designed to actually reduce site workload.

Risk-Based Monitoring

eSource Enabled Risk-Based Monitoring

In the face of increasing clinical trial costs, complexity and regulations, drug makers are under increasing pressure to save money while executing more efficient clinical trials. In an effort to enhance subject protection and clinical trial data quality, the Food and Drug Administration (FDA) issued final industry guidance in August 2013, “Oversight of Clinical Investigations – A Risk-Based Approach to Monitoring”.